Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 6, 2025Open Access

Multi-omics integration predicts 17 disease incidences in the UK Biobank

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJiawen DuMZMuqing ZhouLRLaura M. Raffield

Discussion

Loading...

Member takes

Overview

Analysis shows improved risk prediction for 17 diseases using multi-omics data, indicating the importance of metabolomics and proteomics.

Key Points

  • Multi-omics integration significantly improves risk prediction for 17 diseases compared to clinical predictors alone.
  • Cox proportional hazard models revealed a notable enhancement in predictive performance using omics data.
  • Proteomics generally outperformed metabolomics for predicting 14 out of 17 disease endpoints identified in the study.
  • The findings underline the potential of omics data to refine disease risk models, offering new avenues for clinical application.

Cite This Study

Du et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d1746https://doi.org/10.1101/2025.08.01.25332841
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12247-P: Uncertainty-Calibrated Prediction of Cardiovascular–Kidney–Liver–Metabolic Disease Using Clinical Biomarkers and Plasma Proteomics2026
  2. 2Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk2025 · 8 citations
  3. 3Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes2025
  4. 4Proteomic prediction of disease largely reflects environmental risk exposure2025
  5. 5Mapping the plasma metabolome to human health and disease in 274,241 adults2025 · 1 citations